baber/WOPTO huggingface dataset:
Patent DK-0557192-T3 (DK)
Inventor: BABIN DIDIER
IPC: A01N53/06
Filed: 1993-02-18
Granted: 1996-10-14
Abstract: The subject of the invention, in all the possible stereoisomeric forms and their mixtures, is the compounds of formula (I): <IMAGE>  in which:   - X represents a hydrogen atom, an alkyl, alkenyl or alkynyl radical containing up to 4 carbon atoms or a cyano radical or an aralkynyl radical containing up to 10 carbon atoms,   Y represents a halogen atom or a CH2F, CHF2 or CF3 radical and A represents the residue of an acid used in the pyrethrinoic series.     The compounds of formula (I) have advantageous pesticidal properties.
Patent DK-0648383-T3 (DK)
Inventor: SAUER BERND
IPC: H02K17/16
Filed: 1993-06-05
Granted: 1996-02-05
Abstract: PCT No. PCT/EP93/01429 Sec. 371 Date Sep. 2, 1994 Sec. 102(e) Date Sep. 2, 1994 PCT Filed Jun. 5, 1993 PCT Pub. No. WO94/01918 PCT Pub. Date Jan. 20, 1994.For a squirrel-cage rotor of an electric machine, having a cage that passes through the stack axially and is made of electrically well-conductive short-circuit rods that are connected by short-circuit rings at the ends projecting from the stack, oscillation problems that result during operation with frequency converters are intended to be solved. In addition, higher natural torsion frequencies are intended to be achieved on the rotor, that is, the construction is to be made less sensitive by simple modifications to the squirrel cage in order to prevent the resonance effects. This object is attained in that respectively two, three or more short-circuit rods are guided together to rod assemblies at their ends, and these are connected to the short-circuit rings with material-to-material bonding.
Patent DK-0657536-T3 (DK)
Inventor: WALLACH DAVID
IPC: A61K38/55
Filed: 1994-10-11
Granted: 2001-09-17
Abstract: Molecules which influence the shedding of the cell-bound p55 Tumor Necrosis Factor receptor (p55-TNF-R), are provided, together with methods of producing them. More particularly, the invention relates to proteases which cleave the cell-bound p55 TNF-R thus creating the soluble receptor and to inhibitors to these proteases comprising sequence asn-172 to thr-182 of p55-TNF-R or muteins thereof.
Patent DK-0670863-T3 (DK)
Inventor: PAUL CHARLES W
IPC: C08L101/16
Filed: 1993-11-23
Granted: 1999-03-08
Abstract: There is provided a biodegradable composition as obtained from a melt comprising converted starch, a plasticizer and at least one member selected from alkenol homopolymers and/or alkenol copolymers which are combined under conditions sufficient to ensure uniform melt formation, in which the at least one member is present in the composition at a concentration of from 10 to 200 parts per 100 parts of dry converted starch. The invention further relates to methods of making the composition, and to articles made from said composition.
Patent DK-0674500-T3 (DK)
Inventor: LAVASH BRUCE WILLIAM
IPC: A61F5/44
Filed: 1993-12-13
Granted: 1998-03-16
Abstract: An absorbent article having a main body portion, a pair of flaps joined to the main body portion, and an adhesive patch joined to each flap. Each adhesive patch comprises a first half and a second half releasably secured to the first half. The fist half has adhesive zones and release zones, and the second half has adhesive zones and release zones which are removably securable to the release zones and adhesive zones of the first half.
Patent DK-0710125-T3 (DK)
Inventor: PELLEGRIN ROBERTO
IPC: B09B3/00
Filed: 1994-07-18
Granted: 2000-10-02
Abstract: PCT No. PCT/EP94/02357 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed Jul. 18, 1994 PCT Pub. No. WO95/03072 PCT Pub. Date Feb. 2, 1995A method for heat sterilizing or disinfecting hospital waste includes the steps of grinding and/or comminuting the waste under a cutting force and for an amount of time such that a quantity of heat which is sufficient to reach and maintain the sterilization or disinfection temperature within the massive waste is generated by friction. The apparatus includes a rotor provided with vanes or blades for grinding or comminuting the waste and a plurality of fixed strikers in the form of vanes or blades associated with the walls of the housing.
Patent DK-0704208-T3 (DK)
Inventor: SUEFKE THOMAS DR
IPC: A61K9/28
Filed: 1995-08-28
Granted: 2004-07-12
Abstract: Coating and binding agents for pharmaceutical dosage forms comprise copolymers of 10-25 wt.% methacrylic acid (MAA), 40-70 wt.% methyl acrylate (MA) and 20-40 wt.% methyl methacrylate. The copolymer contains less than 20 wt.% of other components and is used in the form of an aq. latex.
Patent DK-0700949-T3 (DK)
Inventor: LE-KHAC BI
IPC: C08F4/26
Filed: 1995-08-29
Granted: 1999-09-27
Abstract: A solid double metal cyanide (DMC) catalyst useful for epoxide polymerisation comprises: (a) a double metal cyanide cpd; (b) an organic complexing agent; and (c) about 5-80 wt% based on the amt of catalyst, of a polyether having a number average molecular wt greater than about 500. Also claimed are: Preparing a solid DMC catalyst in the presence of an organic complexing agent and a polyether as above, wherein the solid DMC catalyst contains 5-80 wt% of the polyether. Preparing a soli DMC catalyst useful for epoxide polymerisation.
Patent DK-0680972-T3 (DK)
Inventor: PORTEVIN BERNARD
IPC: A61K38/55
Filed: 1995-05-05
Granted: 2000-07-31
Abstract: Peptide derivatives of trifluoromethyl ketones of formula (I), their hydrates, enantiomers, diastereoisomers, epimers, and salts are new. R1, R2 = 1-6C alkyl or 3-7C cycloalkyl; R3 = H, 1-6C alkyl or 3-7C cycloalkyl; R4 = halo, or 1-6C alkyl or alkoxy; R5 = 1-6C alkyl; X, Y = CO or SO2; n = 1, 2, or 3; p = 0 or 1; Z = S or O; A = a gp. of formula (i) or -NR6-CHR7-; A1 with the N and CH forms a 2-azabicyclo(2,2,2)octane, 2-aza bicyclo(2,2,1)heptane, perhydroindole, perhydroisoindole, indoline, isoindoline, perhydroquinoline, perhydroisoquinoline, 1,2,3,4-tetrahydroisoquinoline, 1,2,3,4-tetrahydroquinoline, cyclopenta(b)pyrrolidine, 1,3-thiazolidine, or pyrrolidine ring, R6 = H, 1-6C alkyl, 3-6C cycloalkyl, or indan-2-yl, R7 = H, or 1-6C alkyl.
Patent DK-0729750-T3 (DK)
Inventor: BRETON LIONEL
IPC: A61Q19/00
Filed: 1995-11-28
Granted: 2004-05-10
Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthetic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.
Patent DK-0767676-T3 (DK)
Inventor: SARRAS MICHAEL P JR
IPC: A61M5/32
Filed: 1995-06-30
Granted: 2002-05-21
Abstract: The instant invention demonstrates that the 7S domain of type IV collagen disrupts cell aggregation and tissue development. Structural changes in mesoglea, inhibition of cell proliferation, and changes in cell differentiation patterns accompanies the blockage of cell aggregates which indicate that blockage may be due to alterations in mesoglea (extracellular matrix) structure with accompanying effects on cell behaviour. Type IV collagen has a critical role in the initial formation of mesoglea and that perturbation of mesoglea formation affects cell division, cell differentiation and morphogenesis. <IMAGE>
Patent DK-0744962-T3 (DK)
Inventor: SCHNEIDER MICHEL
IPC: A61K49/00
Filed: 1995-12-14
Granted: 2001-12-31
Abstract: Disclosed are suspensions of gas microbubbles immobilised within a frozen aqueous carrier liquid comprising usual additives and stabilisers, in which the carrier liquid is a physiologically acceptable, the immobilised gas microbubbles are microbubbles bound by an evanescent envelope or a tangible membrane. The suspensions, when in liquid form, are injectable and useful as a contrast agents in ultrasonic imaging of blood pool and tissue of living beings. The gas microbubbles are immobilised within the carrier by freezing a suspension of microbubbles with average sizes below 50  mu m, preferably below 10  mu m and more preferably between 2  mu m and 8  mu m, to a temperature between -1 DEG  C. and -76 DEG  C. and maintaining this temperature for prolonged periods of time. The microbubbles may be stabilised by a surfactant such as a lamellar phospholipid or may comprise a membrane made of synthetic or natural polymer or protein. A method of cold storage of microbubble suspensions as well as their use is also disclosed.
Patent DK-0780052-T3 (DK)
Inventor: SOENNICHSEN DIETER
IPC: A21C11/00
Filed: 1996-12-13
Granted: 2000-09-18
Abstract: A process for producing dough products of a given area and thickness involves pressing a dough preform between a supporting plate(9) and a punch(1). The supporting plate(9) has an initial surface area smaller than the final area of dough and the dough preform is pressed onto the support(9) with a core punch(2) of similar area so that the dough flows radially. After a prescribed flow time the surface area of both core punch(2) and supporting plate(9) are enlarged and further pressure is exerted to continue the increase in area of the dough. The enlarging procedure is repeated progressively in a radial plane accompanied by corresponding pressure applications until the dough has a desired area and thickness. Process apparatus comprises a supporting plate(9) and an opposing, downward-moving punch(1), the latter including a core punch(2) of a given area around which a first(3) and subsequent(4-8) enlarging sections are individually moved to increase the area. The supporting plate (9) likewise comprises a core plate(10) around which a first(11) and subsequent(12-16) enlarging sections are moved. The areas of the core plate(10) and core punch(2) are identical as are those of the corresponding enlarging sections(3-8;11-16). Punch(1) and support plate(9) areas increase at the same rate.
Patent DK-0826483-T3 (DK)
Inventor: MURPHY JAMES C
IPC: B29C70/86
Filed: 1996-08-28
Granted: 2001-11-19
Abstract: The invention relates to a method of manufacturing a fluid containing vessel having a fitting. The steps include forming a liner (10), providing a preformed fitting (14) having a flange; installing an insert (24) in the fitting; and positioning the fitting (14) on a wall of the liner (10) and welding the insert to the wall. Additional steps include filament winding the liner, said filaments capturing the fitting flange against the wall; and cutting a hole through the wall of the liner inside the fitting to create a passage through the fitting and liner wall. Preferably, the fitting (14) defines a passage (18) therethrough and the insert (24) is installed in the passage (18). The insert preferably has a flange (26) that engages the fitting to retain the fitting on the liner. The passage preferably communicates with an interior of the liner through the hole. When the liner and insert are made of materials having substantially similar melting temperatures, they are preferably heated to about the same temperature. When the liner (10) and insert (24) have different melting temperatures, they are preferably heated to different temperatures. The liner 10) and insert (24) are preferably made of materials compatible for welding to each other, preferably plastic. The liner (10) may be generally cylindrical, and the fitting (14) may be located on a generally cylindrical side wall of the liner. The step of welding may include heating the insert (24) and an area of the liner (10) and pressing the insert (24) into the liner to bond therewith. <IMAGE>
Patent DK-0871465-T3 (DK)
Inventor: NORBECK DANIEL W
IPC: C07D277/28
Filed: 1996-06-28
Granted: 2003-02-03
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.
Patent DK-0869760-T3 (DK)
Inventor: MAZER TERRENCE B
IPC: A61J9/00
Filed: 1996-12-12
Granted: 2004-08-02
Abstract: Apparatus for adding a beneficial agent to a liquid for drinking during oral administration includes a support structure extending transversely across an imperforate walled zone such as the upper end or neck of a bottle or vessel, or of a funnel-like adapter attached to the top of the vessel, with a retention pocket with liquid penetrable walls held by the support structure and comprising at least one beneficial agent secured therein whereby the beneficial agent is taken up in the liquid for drinking during or just prior to oral administration. The beneficial agent may be in either or both of controlled release dosage form or non-controlled release dosage form and may be one or more of nutrients, medicaments, probiotics, electrolytes, rehydration solutions and diagnostic agents, to which a flavoring agent may be added. In the novel method a support structure with a retention pocket comprising at least one beneficial agent is provided in a bottle or vessel with the support structure extending transversely of the neck or top of the bottle or vessel or a drinking tube extending thereinto. The bottle or vessel is provided with a liquid for drinking selected from a liquid nutritional product, a beverage or water and the liquid is contacted with the beneficial agent during or just before oral administration thereof.
Patent DK-0894229-T3 (DK)
Inventor: KIROL LANCE D
IPC: F25B41/06
Filed: 1997-04-24
Granted: 2004-06-01
Abstract: A valve assembly includes a refrigerant inlet port and a refrigerant outlet port having a restricted opening, with the inlet port opening at least 2 times larger than the restricted outlet port opening. The valve includes components for opening and closing the inlet port in response to valve cavity pressure between the inlet and outlet ports. The larger inlet port relative to the restricted outlet port provides for rapid pressure buildup in the valve cavity when the inlet port is open which, in turn, causes rapid closing of the inlet port. The valve is capable of rapid cycling rates, highly effective for small refrigeration or cooling apparatus, as well as for controlling pressure in other applications requiring pressure regulation.
Patent DK-0930875-T3 (DK)
Inventor: BREITENBACH JOERG
IPC: A61K9/22
Filed: 1997-09-11
Granted: 2003-09-01
Abstract: A process for producing solid dose forms by mixing at least one polymeric binder, with or without at least one active ingredient and with or without conventional additives, and shaping the mixture, where at least one of the components is employed in liquid form.
Patent DK-0897725-T3 (DK)
Inventor: NICAS THALIA IOANNA
IPC: A61K38/14
Filed: 1998-08-18
Granted: 2004-12-13
Abstract: The present invention is directed to methods for treating infections caused by Staphylococcus aureus with reduced glycopeptide sensitivity. The invention is preferably practiced with strains of Staphylococcus aureus which are methicillin resistant, such as the Mu50 strain.
Patent DK-1053248-T3 (DK)
Inventor: MARSDEN HOWARD SINKINSON
IPC: C07K7/08
Filed: 1998-02-02
Granted: 2007-08-27
Abstract: A multiply-displayed peptide structure is provided for the serodiagnosis of HSV-2 antibodies, preferably by ELISA. The structure has the formula (1)): [(X1)p-16aa sequence-(X2)q-Sp]n-core, wherein "16aa sequence" represents a sequence (SEQ ID NO: 68) -  - Glu Glu Phe Glu Gly Ala Gly Asp Gly Glu Pro Pro -  1               5                  10 - +TR  - Glu Asp Asp Asp - 15      -  X1 and X2 which may be the same or different represent from 1 to 6 non-interfering amino acid residues, which may be the same or different; Sp represents a spacer group extending outwardly from the core; n is at least 4; p is 0 or 1; q is 0 or 1; and the linkage between the core and the spacer group may be chemical or physical. Preferably p is 1, q is 1, X1 is Pro, n is 4, and the core is a branched lysine core, whereby the whole structure is a peptide. The monomeric peptides (X1)p-16aa sequence-(X2)q-(Sp)r, where r is 0 or 1 and their functional derivatives are useful intermediates in preparing the above structures.
Patent DK-0975236-T3 (DK)
Inventor: MERKEL CAROLYN M
IPC: A23L1/308
Filed: 1998-03-31
Granted: 2005-02-07
Abstract: This invention relates to a low calorie, palatable fiber-containing, sugar substitute composition suitable for use as a substitute for table sugar (for use on cereals, fruits, in hot or iced tea and coffee, etc.) and in the preparation of baked foods and other prepared solid and semi-solid foods.
Patent DK-0960187-T3 (DK)
Inventor: ROWLAND BARRY
IPC: C11D3/22
Filed: 1998-08-03
Granted: 2003-02-24
Abstract: The present invention provides a detergent tablet comprising:     a) a compressed portion comprising active detergent components; b) a non compressed, non-encapsulating portion comprising active detergent components. Detergent components which are sensitive to compression can be incorporated into tablets and greater control of washing processes can be achieved.
Patent DK-1018301-T3 (DK)
Inventor: SANCHEZ JAVIER GAMEX A S
IPC: A22C13/00
Filed: 1999-01-08
Granted: 2003-08-11
Abstract: The present invention refers to non-edible collagen casings for foodstuffs which do not have to be soaked in water or brine by the consumer before stuffing. The casings provided in the present invention contain a moisture amount between 27 % and 49 % by weight based on total casing weight, and a salt amount determined by the salt concentration used in the presoaking aqueous solution and the immersion time therein. The salt uptake by the casing ranges between 5 % and 15 % by weight based on dry casing weight. A method of manufacture wherein the casings are presoaked in water or in an aqueous solution of a salt the use of which complies with food and commodity regulations before packing. In a most preferred embodiment the casings are presoaked in a sodium chloride aqueous solution with a concentration between 5 % and 25 % of sodium chloride, and preferably between 10 % and 20 %. The casings are finally packed under protective gas or under vacuum.
Patent DK-1047645-T3 (DK)
Inventor: HANSEN ERLING LENNART
IPC: C03C25/24
Filed: 1999-01-15
Granted: 2007-05-21
Abstract: Compound or salts thereof suitable for use as a binder for mineral fibers, for example glass or stone wool, said compound containing a carboxylic acid group and/or a beta-hydroxyalkyl amide group.
Patent ES-2259946-T3 (ES)
Title: Sistema para la sincronizacion de al menos un modulo distanciado con un modulo central.
Inventor: DAUERER J-RG
IPC: H04J3/06
Filed: 2000-01-26
Granted: 2006-11-01
Abstract: Sistema para la sincronización de al menos un módulo distanciado (CU) con un módulo central (CORE), en el que el módulo central (CORE) presenta: - un equipo (ACLK) para generar una señal de impulsos del sistema (mclk), - un primer equipo de cómputo (COUNT1) para generar periódicamente un impulso de sincronización (msync) a partir de la señal de impulsos del sistema (mclk), generándose el impulso de sincronización (msync) con una periodicidad que se corresponde con un divisor común entero de una periodicidad de la señal de impulsos del sistema (mclk) y una periodicidad de una señal de impulsos local (lclk) generada en el módulo distanciado (CU), y - un primer equipo de interfaz (SELIC1) para enviar informaciones y el impulso de sincronización (msync) a través de al menos una línea de enlace (CC-LINK) al módulo distanciado (CU), y el módulo distanciado (CU) presenta: - un equipo (LCLK) para generar la señal de impulsos local (lclk), - un segundo equipo de interfaz (SELIC2) para recibir las informaciones transmitidas a través de la línea de enlace (CC- LINK) y el impulso de sincronización (msync), y - un equipo de sincronización (SYNCGATE) para calcular la correspondiente diferencia entre una posición en el tiempo del impulso de sincronización (msync) recibido y una posición en el tiempo de la señal de impulsos local (lclk), y para el control de la posición en el tiempo de la señal de impulsos local (lclk) en relación con la posición en el tiempo del impulso de sincronización (msync).
Patent ES-2218018-T3 (ES)
Inventor: KRUMM VALENTIN
IPC: D03D47/34
Filed: 2000-03-17
Granted: 2004-11-16
Abstract: To avoid a delay in the braking action when a loom is stopped, especially with a combined brake/clutch between the drive and loom main shaft, the switch action to interrupt weaving is selectively on a weft break between the supply bobbin and the wound w store in the feed system when an electrical signal is generated, or when another criterion at the program control is achieved. The other criterion at the program control is a given number of weft insertions without a break in the weaving, or continuo uninterrupted weaving for a given time span. The switch action to stop the loom is effected when the first criterion in the prog control generates an electrical signal. Or the loom stop switch is triggered exclusively on an electrical signal showing a weft break between the supply and feed points.
Patent ES-2304339-T3 (ES)
Inventor: SMOLDERS RAYMOND
IPC: B62D7/02
Filed: 2000-11-24
Granted: 2008-10-16
Abstract: The machine has a frame (4) with longitudinal and cross struts and a chassis (2). A sliding crosshead (22) moveable in working direction, is fastened to one of the cross struts (20), and height-adjustable travellers (14,15) are fastened to the siding crosshead. The longitudinal struts (8) are telescopic, and the cross strut is fastened to the free ends of the longitudinal struts. The sliding crosshead carries a pivot unit, pivoted in the plane of the machine frame, for a conveyor.
Patent ES-2200830-T3 (ES)
Title: Anillo de apriete; procedimiento de fabricacion e instalacion de fabricacion.
Inventor: ANDRE MICHEL
IPC: B21D39/03
Filed: 2000-02-25
Granted: 2004-03-16
Abstract: Procedimiento de fabricación de un anillo de apriete, que comprende una banda o cinta metálica (10, 110, 210) enrollada sobre sí misma, cuyos extremos (10A, 10B; 110A, 110B; 210A, 210B) se enlazan mediante un elemento de unión (12; 22; 32; 42; 112; 142; 212), que presenta al menos un borde de anclaje (14; 24, 25, 27; 34, 39; 43, 44; 114; 145, 147; 225, 227), caracterizado por el hecho de que, para unir el susodicho elemento de unión a un extremo (10A, 10B; 110B; 210A, 210B) de la banda (10, 110, 210), se coloca el elemento de unión contra el susodicho extremo de tal suerte que el susodicho borde de anclaje del elemento de unión se sitúe enfrente de este extremo y se ejerce una presión sobre el elemento de unión (12; 22; 32; 42; 112; 142; 212) a fin de hacer retroceder el material del susodicho extremo de la banda, que se halla debajo del elemento de unión, proveyendo dentro de este extremo un órgano de fijación (15; 25¿; 27¿; 35, 39¿; 225¿, 227¿) apto para cooperar con el susodicho borde deanclaje a fin de retener, el uno con respecto al otro, el elemento de unión y el susodicho extremo de la banda, de tal suerte que el espesor (E) del anillo en la zona del elemento de unión sea prácticamente igual al espesor (E¿) de la banda.